Affinia Therapeutics an innovative gene therapy company with a pipeline of rationally designed adeno-associated virus (AAV) gene therapies for devastating cardiovascular and neurological diseases,...
BioVentrix, Inc., a specialty medical device company serving cardiothoracic surgeons and their patients with lifesaving heart failure therapies, announced as the appointment of Steven...
Innovent Biologics, Inc, a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...
Maze Therapeutics, a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal,...
Alessandra Vignola has joined Worldwide Clinical Trials (Worldwide), a global full-service contract research organization (CRO), as President of the Cardiovascular & Metabolic Business Unit. Vignola brings...
